跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 29,031 条关于
“ALT-100 mAb”
全部
29,031
临床试验
14,944
药物
5,742
机构
584
资讯
7,761
9个月前
Aqualung Therapeutics Receives FDA Clearance for Phase 2a Progressive Pulmonary Fibrosis Trial
2个月前
Monoclonal Antibody ALT-100 Shows Early Promise for ARDS in Proof-of-Concept Trial
3年前
I-Mab Announces 2022 Financial Results and Pipeline Updates, Highlighting Key Clinical Milestones
去年
Brelovitug Receives FDA Breakthrough Therapy Designation for Chronic Hepatitis Delta
去年
I-Mab Acquires Bridge Health Biotech to Strengthen Givastomig Bispecific Antibody Development
3年前
Error parsing response
2年前
I-Mab Advances Immunotherapy Pipeline with Uliledlimab, Givastomig, and Ragistomig
9天前
Alteogen licenses ALT-B4 to Novartis in deal worth up to $3.2 billion
去年
Tenofovir Amibufenamide Shows Significant Efficacy in Chronic Hepatitis B Patients with Normal ALT Levels
去年
I-Mab Prioritizes Givastomig for Gastric Cancer Treatment, Pauses Uliledlimab Development
第 1 页,共 777 页
上一页
下一页